Clinical Trial Update: AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma [Phase 2]

View source ↗

Summary

Amgen's Phase 2 trial of AMG 853 in inadequately controlled asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AMG 853

Snippet

Sponsor: Amgen | Conditions: Asthma | Phase 2 | Status: COMPLETED